Morphocell Technologies is a regenerative medicine company.
Morphocell Technologies has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Morphocell Technologies's investors include CDP Venture Capital, Investissement Quebec, Genson Capital.
Morphocell Technologies is headquartered in Montréal, Canada.
Morphocell Technologies is a regenerative medicine company.
Morphocell Technologies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Morphocell Technologies — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/morphocell-technologies. Accessed July 20, 2026.
VCBacked. (2025). Morphocell Technologies — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/morphocell-technologies
{{cite web |title=Morphocell Technologies — Funding & Investors |url=https://www.vcbacked.co/company/morphocell-technologies |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated